Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer

Kluth,Martina; Galal,Rami; Krohn,Antje; Weischenfeldt,Joachim; Tsourlakis,Christina; Paustian,Lisa; Ahrary,Ramin; Ahmed,Malik; Scherzai,Sekander; Meyer,Anne; Sirma,Hüseyin; Korbel,Jan; Sauter,Guido; Schlomm,Thorsten; Simon,Ronald; Minner,Sarah

doi:10.3892/ijo.2015.2855

April-2015 Volume 46 Issue 4

Full Size Image

Cover Legend PDF

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

April-2015 Volume 46 Issue 4

Full Size Image

Cover Legend PDF

Article

Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer

Authors:
- Martina Kluth
- Rami Galal
- Antje Krohn
- Joachim Weischenfeldt
- Christina Tsourlakis
- Lisa Paustian
- Ramin Ahrary
- Malik Ahmed
- Sekander Scherzai
- Anne Meyer
- Hüseyin Sirma
- Jan Korbel
- Guido Sauter
- Thorsten Schlomm
- Ronald Simon
- Sarah Minner
View Affiliations / Copyright

Affiliations: Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Genome Biology Unit, European Molecular Biology Laboratory (EMBL), D-69117 Heidelberg, Germany, Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Pages: 1637-1642
|
Published online on: January 27, 2015

https://doi.org/10.3892/ijo.2015.2855
Expand metrics +

Abstract

Prostate cancer is characterized by structural rearrangements, most frequently including translocations between androgen-dependent genes and members of the ETS family of transcription factor like TMPRSS2:ERG. In a recent whole genome sequencing study we identified 140 gene fusions that were unrelated to ETS genes in 11 prostate cancers. The aim of the present study was to estimate the prevalence of non-ETS gene fusions. We randomly selected 27 of these rearrangements and analyzed them by fluorescence in situ hybridization (FISH) in a tissue microarray format containing 500 prostate cancers. Using break-apart FISH probes for one fusion partner each, we found rearrangements of 13 (48%) of the 27 analyzed genes in 300-400 analyzable cancers per gene. Recurrent breakage, often accompanied by partial deletion of the genes, was found for NCKAP5, SH3BGR and TTC3 in 3 (0.8%) tumors each, as well as for ARNTL2 and ENOX1 in 2 (0.5%) cancers each. One rearranged tumor sample was observed for each of VCL, ZNF578, IMMP2L, SLC16A12, PANK1, GPHN, LRP1 and ZHX2. Balanced rearrangements, indicating possible gene fusion, were found for ZNF578, SH3BGR, LPR12 and ZHX2 in individual cancers only. The results of the present study confirm that rearrangements involving non-ETS genes occur in prostate cancer, but demonstrate that they are highly individual and typically non-recurrent.

View Figures

View References

1	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
2	Sjoblom T, Jones S, Wood LD, et al: The consensus coding sequences of human breast and colorectal cancers. Science. 314:268–274. 2006. View Article : Google Scholar : PubMed/NCBI
3	Wood LD, Parsons DW, Jones S, et al: The genomic landscapes of human breast and colorectal cancers. Science. 318:1108–1113. 2007. View Article : Google Scholar : PubMed/NCBI
4	Berger MF, Lawrence MS, Demichelis F, et al: The genomic complexity of primary human prostate cancer. Nature. 470:214–220. 2011. View Article : Google Scholar : PubMed/NCBI
5	Weischenfeldt J, Simon R, Feuerbach L, et al: Integrative genomic analyses reveal androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell. 23:159–170. 2013. View Article : Google Scholar : PubMed/NCBI
6	Barbieri CE, Baca SC, Lawrence MS, et al: Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet. 44:685–689. 2012. View Article : Google Scholar : PubMed/NCBI
7	Grasso CS, Wu YM, Robinson DR, et al: The mutational landscape of lethal castration-resistant prostate cancer. Nature. 487:239–243. 2012. View Article : Google Scholar : PubMed/NCBI
8	Tomlins SA, Rhodes DR, Perner S, et al: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 310:644–648. 2005. View Article : Google Scholar : PubMed/NCBI
9	Tomlins SA, Bjartell A, Chinnaiyan AM, et al: ETS gene fusions in prostate cancer: from discovery to daily clinical practice. Eur Urol. 56:275–286. 2009. View Article : Google Scholar : PubMed/NCBI
10	Shao L, Tekedereli I, Wang J, et al: Highly specific targeting of the TMPRSS2/ERG fusion gene using liposomal nanovectors. Clin Cancer Res. 18:6648–6657. 2012. View Article : Google Scholar : PubMed/NCBI
11	Hudson TJ, Anderson W, Artez A, et al: International network of cancer genome projects. Nature. 464:993–998. 2010. View Article : Google Scholar : PubMed/NCBI
12	Schlomm T, Chun F and Erbersdobler A: From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer. Methods Mol Biol. 664:177–189. 2010. View Article : Google Scholar : PubMed/NCBI
13	Minner S, Jessen B, Stiedenroth L, et al: Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer. Clin Cancer Res. 16:1553–1560. 2010. View Article : Google Scholar : PubMed/NCBI
14	Reid AH, Attard G, Brewer D, et al: Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer. Mod Pathol. 25:902–910. 2012. View Article : Google Scholar : PubMed/NCBI
15	Krohn A, Seidel A, Burkhardt L, et al: Recurrent deletion of 3p13 targets multiple tumor suppressor genes and defines a distinct subgroup of aggressive ERG fusion positive prostate cancers. J Pathol. 231:130–141. 2013. View Article : Google Scholar : PubMed/NCBI
16	Korbel JO, Urban AE, Affourtit JP, et al: Paired-end mapping reveals extensive structural variation in the human genome. Science. 318:420–426. 2007. View Article : Google Scholar : PubMed/NCBI
17	Krohn A, Diedler T, Burkhardt L, et al: Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer. Am J Pathol. 181:401–412. 2012. View Article : Google Scholar : PubMed/NCBI
18	Sun J, Liu W, Adams TS, et al: DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies. Prostate. 67:692–700. 2007. View Article : Google Scholar : PubMed/NCBI
19	Taylor BS, Schultz N, Hieronymus H, et al: Integrative genomic profiling of human prostate cancer. Cancer Cell. 18:11–22. 2010. View Article : Google Scholar : PubMed/NCBI
20	Minner S, Enodien M, Sirma H, et al: ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy. Clin Cancer Res. 17:5878–5888. 2011. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer

This article is mentioned in:

Abstract

Figure 1

Related Articles